• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性心肌梗死中的心房颤动:发病率、临床特征及预后影响的系统评价

Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications.

作者信息

Schmitt Joern, Duray Gabor, Gersh Bernard J, Hohnloser Stefan H

机构信息

Section of Electrophysiology, Division of Cardiology, J.W. Goethe University, Theodor-Stern-Kai 7, D 60590 Frankfurt, Germany.

出版信息

Eur Heart J. 2009 May;30(9):1038-45. doi: 10.1093/eurheartj/ehn579. Epub 2008 Dec 24.

DOI:10.1093/eurheartj/ehn579
PMID:19109347
Abstract

Atrial fibrillation (AF), the most commonly encountered clinical arrhythmia, often complicates acute myocardial infarction (AMI) with an incidence between 6 and 21%. Predictors of the arrhythmia in the setting of AMI include advanced age, heart failure symptoms, and depressed left ventricular function. The bulk of evidence demonstrates that AF in patients hospitalized for AMI has serious adverse prognostic implications regarding in-hospital, but also long-term mortality. This seems to apply for all patient populations studied without significant differences related to the treatment of AMI (i.e. no reperfusion therapy vs. thrombolysis vs. percutaneous coronary intervention). Mortality is particularly high in patients who have congestive heart failure and/or a reduced left ventricular ejection fraction. Finally, there are persuasive data indicating that AF complicating AMI not only increases the risk for ischaemic stroke during hospitalization but also during follow-up. This seems to apply also for transient AF which has reversed back to sinus rhythm at the time of discharge. These observations emphasize the need for prospective studies evaluating optimal therapeutic approaches for patients with AMI complicated by AF.

摘要

心房颤动(AF)是临床上最常见的心律失常,常使急性心肌梗死(AMI)复杂化,发生率在6%至21%之间。AMI患者发生这种心律失常的预测因素包括高龄、心力衰竭症状和左心室功能低下。大量证据表明,因AMI住院的患者发生AF对住院期间以及长期死亡率均有严重不良预后影响。这似乎适用于所有研究的患者群体,与AMI的治疗方法(即未进行再灌注治疗、溶栓治疗或经皮冠状动脉介入治疗)无关,没有显著差异。充血性心力衰竭和/或左心室射血分数降低的患者死亡率尤其高。最后,有确凿的数据表明,并发AF的AMI不仅增加了住院期间缺血性卒中的风险,也增加了随访期间的风险。这似乎也适用于出院时已恢复窦性心律的短暂性AF。这些观察结果强调了有必要进行前瞻性研究,以评估并发AF的AMI患者的最佳治疗方法。

相似文献

1
Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications.急性心肌梗死中的心房颤动:发病率、临床特征及预后影响的系统评价
Eur Heart J. 2009 May;30(9):1038-45. doi: 10.1093/eurheartj/ehn579. Epub 2008 Dec 24.
2
Beta-blockers in patients without heart failure after myocardial infarction.心肌梗死后无心力衰竭的患者使用β受体阻滞剂。
Cochrane Database Syst Rev. 2021 Nov 5;11(11):CD012565. doi: 10.1002/14651858.CD012565.pub2.
3
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
4
Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis.非维生素 K 拮抗剂口服抗凝药(NOACs)在急性心肌梗死治疗中的应用:一项网状荟萃分析。
Cochrane Database Syst Rev. 2024 Jan 24;1(1):CD014678. doi: 10.1002/14651858.CD014678.pub2.
5
Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.心房颤动和典型心房扑动的根治性导管消融术:系统评价与经济评估
Health Technol Assess. 2008 Nov;12(34):iii-iv, xi-xiii, 1-198. doi: 10.3310/hta12340.
6
Association of Atrial Fibrillation Burden With Cardiovascular Outcomes in New-Onset Atrial Fibrillation Complicating Myocardial Infarction.新发房颤合并心肌梗死时房颤负荷与心血管结局的关联
J Am Heart Assoc. 2025 May 20;14(10):e039547. doi: 10.1161/JAHA.124.039547. Epub 2025 Apr 16.
7
Antiplatelet versus anticoagulation treatment for people with heart failure in sinus rhythm.窦性心律心力衰竭患者的抗血小板治疗与抗凝治疗对比
Cochrane Database Syst Rev. 2025 Jun 11;6(6):CD003333. doi: 10.1002/14651858.CD003333.pub4.
8
Systematic review of the management of atrial fibrillation in patients with heart failure.心力衰竭患者心房颤动管理的系统评价
Eur Heart J. 2000 Apr;21(8):614-32. doi: 10.1053/euhj.1999.1767.
9
External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.体外电复律和药物复律治疗心房颤动、心房扑动或房性心动过速的网状 Meta 分析。
Cochrane Database Syst Rev. 2024 Jun 3;6(6):CD013255. doi: 10.1002/14651858.CD013255.pub2.
10
Remote ischaemic preconditioning for coronary artery bypass grafting (with or without valve surgery).用于冠状动脉搭桥术(伴或不伴瓣膜手术)的远程缺血预处理
Cochrane Database Syst Rev. 2017 May 5;5(5):CD011719. doi: 10.1002/14651858.CD011719.pub3.

引用本文的文献

1
Evaluation of ambulatory electrocardiographic monitoring of patients after high-risk acute coronary syndrome: the MONITOR ACS-Epic 13 randomized trial.高危急性冠状动脉综合征患者动态心电图监测的评估:MONITOR ACS-Epic 13随机试验
Front Cardiovasc Med. 2025 Aug 18;12:1646175. doi: 10.3389/fcvm.2025.1646175. eCollection 2025.
2
The impact of chronic kidney disease on the antithrombotic strategies and outcomes in patients with acute coronary syndromes and atrial fibrillation: Insights from STAR-ACS study.慢性肾脏病对急性冠脉综合征和心房颤动患者抗栓策略及预后的影响:来自STAR-ACS研究的见解
Int J Cardiol Cardiovasc Risk Prev. 2025 Aug 13;27:200486. doi: 10.1016/j.ijcrp.2025.200486. eCollection 2025 Dec.
3
Long-term risk of stroke after acute coronary syndrome: the ABC-10* study on heart disease.
急性冠状动脉综合征后中风的长期风险:ABC-10* 心脏病研究
BMC Cardiovasc Disord. 2025 Aug 21;25(1):623. doi: 10.1186/s12872-025-05040-9.
4
Prognostic impact of early and late newly diagnosed atrial fibrillation in acute myocardial infarction treated with percutaneous coronary intervention.经皮冠状动脉介入治疗急性心肌梗死时,早期和晚期新诊断房颤的预后影响
BMC Cardiovasc Disord. 2025 Jul 31;25(1):557. doi: 10.1186/s12872-025-05020-z.
5
HATCH score associated with new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction.ST段抬高型心肌梗死患者新发房颤的HATCH评分
BMC Cardiovasc Disord. 2025 Jul 16;25(1):516. doi: 10.1186/s12872-025-04989-x.
6
Incremental prognostic value of left atrial reservoir strain after ST-segment elevation myocardial infarction for the prediction of new-onset atrial fibrillation.ST段抬高型心肌梗死后左心房储备应变对预测新发心房颤动的增量预后价值。
Int J Cardiovasc Imaging. 2025 Jul 5. doi: 10.1007/s10554-025-03458-y.
7
Atrial Fibrillation Is Associated With Increased In-Hospital and 1-Year Mortality in Patients Receiving Hemodialysis With ST Elevation Myocardial Infarction: A Retrospective Cohort Study.心房颤动与接受血液透析的ST段抬高型心肌梗死患者住院期间及1年死亡率增加相关:一项回顾性队列研究。
Kidney Med. 2025 May 12;7(7):101023. doi: 10.1016/j.xkme.2025.101023. eCollection 2025 Jul.
8
Position Statement on Antiplatelet Therapy for East Asians With Coronary Artery Disease: 2025 Update.《2025年东亚冠状动脉疾病患者抗血小板治疗立场声明更新版》
JACC Asia. 2025 Jul;5(7):821-846. doi: 10.1016/j.jacasi.2025.04.010.
9
Administration with ameliorates the progression of atrial fibrillation by affecting atrial remodeling and oxidative stress via the activation of the PI3K/AKT signaling.通过激活PI3K/AKT信号通路影响心房重构和氧化应激,[药物名称]给药可改善心房颤动的进展。
Cytotechnology. 2025 Jun;77(3):121. doi: 10.1007/s10616-025-00778-8. Epub 2025 Jun 9.
10
Atrial ischemia and incident atrial fibrillation: An unexpected turn of events?心房缺血与新发房颤:意外的事件转折?
Int J Cardiol Heart Vasc. 2025 May 10;58:101701. doi: 10.1016/j.ijcha.2025.101701. eCollection 2025 Jun.